Hydrocortisone-loaded poly(ε-caprolactone) nanoparticles for atopic dermatitis treatment

References

• Buys LM. Treatment options for atopic dermatitis. Am Fam Physician 2007;75:523–528.
   PubMed Web of Science ®Google Scholar
• Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis–part I: clinical and pathologic concepts. J Allergy Clin Immunol 2011;127:1110–1118.
   PubMed Web of Science ®Google Scholar
• Del Rosso JQ, Bhambri S. Daily application of fluocinonide 0.1% cream for the treatment of atopic dermatitis. J Clin Aesthet Dermatol 2009;2:24–32.
   PubMedGoogle Scholar
• Meireles C, Hergy F, Mousinho MC, Afonso S, Rosado C. Characteristics of infantile skin of the cosmetic products formulated for this age group. Rev Lusófona de Ciências e Tecnologias da Saúde 2007;4:73–80.
   Google Scholar
• Novak N, Leung DY. Advances in atopic dermatitis. Curr Opin Immunol 2011;23:778–783.
   PubMed Web of Science ®Google Scholar
• Atherton DJ. Topical corticosteroids in atopic dermatitis. BMJ 2003;327:942–943.
   PubMedGoogle Scholar
• Ference JD, Last AR. Choosing topical corticosteroids. Am Fam Physician 2009;79:135–140.
   PubMed Web of Science ®Google Scholar
• Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems. Nanomedicine 2006;2:53–65.
   PubMed Web of Science ®Google Scholar
• Bhowmik D, Chiranjib, Chandira RM, Jayakar B. Role of nanotechnology in novel drug delivery system. JPST 2009;1:20–35.
   Google Scholar
• Hughes GA. Nanostructure-mediated drug delivery. Nanomedicine 2005;1:22–30.
   PubMed Web of Science ®Google Scholar
• Chen H, Chang X, Du D, Li J, Xu H, Yang X. Microemulsion-based hydrogel formulation of ibuprofen for topical delivery. Int J Pharm 2006;315:52–58.
   PubMed Web of Science ®Google Scholar
• Couvreur P, Puisieux F. Nano- and microparticles for the delivery of polypeptides and proteins. Adv Drug Deliv Rev 1993;10:141–162.
   Web of Science ®Google Scholar
• Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 2002;6:319–327.
   Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 2010;75:1–18.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int J Pharm 2004;278:1–23.
   PubMed Web of Science ®Google Scholar
• Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H. Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res 2004;21:1818–1825.
   PubMed Web of Science ®Google Scholar
• Ourique AF, Melero A, de Bona da Silva C, Schaefer UF, Pohlmann AR, Guterres SS et al. Improved photostability and reduced skin permeation of tretinoin: development of a semisolid nanomedicine. Eur J Pharm Biopharm 2011;79:95–101.
   PubMed Web of Science ®Google Scholar
• Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine 2006;2:8–21.
   PubMed Web of Science ®Google Scholar
• Nara S, Tripathi V, Singh H, Shrivastav TG. Colloidal gold probe based rapid immunochromatographic strip assay for cortisol. Anal Chim Acta 2010;682:66–71.
   PubMed Web of Science ®Google Scholar
• Boddu SH, Jwala J, Vaishya R, Earla R, Karla PK, Pal D et al. Novel nanoparticulate gel formulations of steroids for the treatment of macular edema. J Ocul Pharmacol Ther 2010;26:37–48.
   PubMed Web of Science ®Google Scholar
• Cavalli R, Peira E, Caputo O, Gasco MR. Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrins. Int J Pharm 1999;182:59–69.
   PubMed Web of Science ®Google Scholar
• Jensen LB, Magnussson E, Gunnarsson L, Vermehren C, Nielsen HM, Petersson K. Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles. Int J Pharm 2010;390:53–60.
   PubMed Web of Science ®Google Scholar
• Vandervoort J, Ludwig A. Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use. Eur J Pharm Biopharm 2004;57:251–261.
   PubMed Web of Science ®Google Scholar
• Lee CM, Lim S, Kim GY, Kim DW, Rhee JH, Lee KY. Rosin nanoparticles as a drug delivery carrier for the controlled release of hydrocortisone. Biotechnol Lett 2005;27:1487–1490.
   PubMed Web of Science ®Google Scholar
• Rosado C, Silva C, Reis CP. Hydrocortisone nanoparticles for atopic dermatitis treatment. SOFW J 2011;137:2–7.
   Google Scholar
• Jenning V, Gysler A, Schäfer-Korting M, Gohla SH. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 2000;49:211–218.
   PubMed Web of Science ®Google Scholar
• Pople PV, Singh KK. Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis. Int J Pharm 2010;398:165–178.
   PubMed Web of Science ®Google Scholar
• Brown KK, Rehmus WE, Kimball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol 2006;55:607–613.
   PubMed Web of Science ®Google Scholar
• Brown KL, Krejci-Manwaring J, Tusa MG, Camacho F, Fleischer AB Jr, Balkrishnan R et al. Poor compliance with topical corticosteroids for atopic dermatitis despite severe disease. Dermatol Online J 2008;14:13.
   PubMedGoogle Scholar
• Gelbard CM, Hebert AA. New and emerging trends in the treatment of atopic dermatitis. Patient Prefer Adherence 2008;2:387–392.
   PubMedGoogle Scholar
• Jetzer WE, Huq AS, Ho NF, Flynn GL, Duraiswamy N, Condie L Jr. Permeation of mouse skin and silicone rubber membranes by phenols: relationship to in vitro partitioning. J Pharm Sci 1986;75:1098–1103.
   PubMed Web of Science ®Google Scholar
• Twist JN, Zatz JL. (1986). Influence of solvents on paraben permeation through idealised skin model membranes. J Soc Cosm Chem 37:429–444.
   Web of Science ®Google Scholar
• Gelotte KM, Lostritto RT. Solvent interaction with polydimethylsiloxane membranes and its effects on benzocaine solubility and diffusion. Pharm Res 1990;7:523–529.
   PubMed Web of Science ®Google Scholar
• Buschini A, Poli P, Rossi C. Saccharomyces cerevisiae as an eukaryotic cell model to assess cytotoxicity and genotoxicity of three anticancer anthraquinones. Mutagenesis 2003;18:25–36.
   PubMed Web of Science ®Google Scholar
• Marrot L, Labarussiat A, Perez P, Meunier JR. Use of the yeast Saccharomyces cerevisiae as a pre-screening approach for assessment of chemical-induced phototoxicity. Toxicol In Vitro 2006;20:1040–1050.
   PubMed Web of Science ®Google Scholar
• Roberto A, Caetano PP. A high-throughput screening method for general cytotoxicity. Part I: chemical toxcity. Rev Lusófona de Ciências e Tecnologias da Saúde 2005;2:95–100.
   Google Scholar
• Al-Kassas RS, Al-Gohary OM, Al-Faadhel MM. Controlling of systemic absorption of gliclazide through incorporation into alginate beads. Int J Pharm 2007;341:230–237.
   PubMed Web of Science ®Google Scholar
• Törmä H, Lindberg M, Berne B. Skin barrier disruption by sodium lauryl sulfate-exposure alters the expressions of involucrin, transglutaminase 1, profilaggrin, and kallikreins during the repair phase in human skin in vivo. J Invest Dermatol 2008;128:1212–1219.
   PubMed Web of Science ®Google Scholar
• Rosado C, Lourenço A, Rodrigues LM. Assessment of the impact of a cream containing urea in skin barrier function. Rev Lusófona de Ciências e Tecnologias da Saúde 2008;2:166–173.
   Google Scholar
• Hammady T, El-Gindy A, Lejmi E, Dhanikula RS, Moreau P, Hildgen P. Characteristics and properties of nanospheres co-loaded with lipophilic and hydrophilic drug models. Int J Pharm 2009;369:185–195.
   PubMed Web of Science ®Google Scholar
• Layre AM, Gref R, Richard J, Requier D, Chacun H, Appel M et al. Nanoencapsulation of a crystalline drug. Int J Pharm 2005;298:323–327.
   PubMed Web of Science ®Google Scholar
• Musumeci T, Ventura CA, Giannone I, Ruozi B, Montenegro L, Pignatello R et al. PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm 2006;325:172–179.
   PubMed Web of Science ®Google Scholar
• Raiman J, Hänninen K, Kontturi K, Murtomäki L, Hirvonen J. Drug adsorption in human skin: a streaming potential study. J Pharm Sci 2003;92:2366–2372.
   PubMed Web of Science ®Google Scholar
• Desai P, Patlolla RR, Singh M. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol Membr Biol 2010;27:247–259.
   PubMed Web of Science ®Google Scholar
• Baroli B. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? J Pharm Sci 2010;99:21–50.
   PubMed Web of Science ®Google Scholar
• Morykwas MJ, Thornton JW, Bartlett RH. Zeta potential of synthetic and biological skin substitutes: effects on initial adherence. Plast Reconstr Surg 1987;79:732–739.
   PubMed Web of Science ®Google Scholar
• Jung S, Otberg N, Thiede G, Richter H, Sterry W, Panzner S et al. Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. J Invest Dermatol 2006;126:1728–1732.
   PubMed Web of Science ®Google Scholar
• Kohli AK, Alpar HO. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. Int J Pharm 2004;275:13–17.
   PubMed Web of Science ®Google Scholar
• Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 2011;63:470–491.
   PubMed Web of Science ®Google Scholar
• Liang CH, Chou TH. Effect of chain length on physicochemical properties and cytotoxicity of cationic vesicles composed of phosphatidylcholines and dialkyldimethylammonium bromides. Chem Phys Lipids 2009;158:81–90.
   PubMed Web of Science ®Google Scholar
• Okada S, Hiroshige R, Tanaka M, Murai M, Kimura T. [Hydrocortisone Acetate Reference Standard (Control 891) of National Institute of Hygienic Sciences]. Eisei Shikenjo Hokoku 1990;108:147–149.
   PubMedGoogle Scholar
• Raghavan SL, Kiepfer B, Davis AF, Kazarian SG, Hadgraft J. Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers. Int J Pharm 2001;221:95–105.
   PubMed Web of Science ®Google Scholar
• Verma D, Katti K, Katti D. Experimental investigation of interfaces in hydroxyapatite/polyacrylic acid/polycaprolactone composites using photoacoustic FTIR spectroscopy. J Biomed Mater Res A 2006;77:59–66.
   PubMed Web of Science ®Google Scholar
• Vogel C, Wessel E, Siesler HW. FT-IR imaging spectroscopy of phase separation in blends of poly(3-hydroxybutyrate) with poly(L-lactic acid) and poly(epsilon-caprolactone). Biomacromolecules 2008;9:523–527.
   PubMed Web of Science ®Google Scholar
• Medina C, Santos-Martinez MJ, Radomski A, Corrigan OI, Radomski MW. Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol 2007;150:552–558.
   PubMed Web of Science ®Google Scholar
• Hoetzenecker W, Meingassner JG, Ecker R, Stingl G, Stuetz A, Elbe-Bürger A. Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J Invest Dermatol 2004;122:673–684.
   PubMed Web of Science ®Google Scholar
• Komine M. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment:keratinocytes in atopic dermatitis - their pathogenic involvement. J Pharmacol Sci 2009;110:260–264.
   PubMed Web of Science ®Google Scholar
• Le Ray AM, Chiffoleau S, Iooss P, Grimandi G, Gouyette A, Daculsi G et al. Vancomycin encapsulation in biodegradable poly(epsilon-caprolactone) microparticles for bone implantation. Influence of the formulation process on size, drug loading, in vitro release and cytocompatibility. Biomaterials 2003;24:443–449.
   PubMed Web of Science ®Google Scholar
• Chawla JS, Amiji MM. Biodegradable poly(epsilon -caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 2002;249:127–138.
   PubMed Web of Science ®Google Scholar
• De Jong WH, Borm PJ. Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine 2008;3:133–149.
   PubMed Web of Science ®Google Scholar